Oragenics Inc
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to redu… Read more
Oragenics Inc (OGEN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.304x
Based on the latest financial reports, Oragenics Inc (OGEN) has a cash flow conversion efficiency ratio of -0.304x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.98 Million) by net assets ($9.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oragenics Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Oragenics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oragenics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oragenics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Winfarm
PA:ALWF
|
0.152x |
|
NETCLASS TECHNOLOGY INC Class A Ordinary Shares
NASDAQ:NTCL
|
0.006x |
|
KC Property PLC
BK:KC
|
-0.095x |
|
Goyal Aluminiums Limited
NSE:GOYALALUM
|
0.038x |
|
Tirta Mahakam Resources Tbk
JK:TIRT
|
0.003x |
|
Roquefort Therapeutics plc
PINK:ROQAF
|
N/A |
|
Manufatura de Brinquedos Estrela SA
SA:ESTR3
|
1.056x |
|
Bank Leumi Le-Israel B.M
TA:LUMI
|
-0.047x |
Annual Cash Flow Conversion Efficiency for Oragenics Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Oragenics Inc from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-211.88K | $-8.60 Million | 40.576x | +1863.16% |
| 2023-12-31 | $3.17 Million | $-7.29 Million | -2.301x | -96.59% |
| 2022-12-31 | $13.01 Million | $-15.23 Million | -1.171x | -130.17% |
| 2021-12-31 | $26.49 Million | $-13.47 Million | -0.509x | +49.47% |
| 2020-12-31 | $16.84 Million | $-16.95 Million | -1.006x | -33.27% |
| 2019-12-31 | $17.23 Million | $-13.01 Million | -0.755x | -73.68% |
| 2018-12-31 | $20.88 Million | $-9.08 Million | -0.435x | +56.84% |
| 2017-12-31 | $6.32 Million | $-6.36 Million | -1.008x | +57.77% |
| 2016-12-31 | $2.97 Million | $-7.08 Million | -2.386x | -121.11% |
| 2015-12-31 | $4.73 Million | $-5.10 Million | -1.079x | -100.60% |
| 2014-12-31 | $10.34 Million | $-5.56 Million | -0.538x | -25.93% |
| 2013-12-31 | $15.84 Million | $-6.76 Million | -0.427x | +24.35% |
| 2012-12-31 | $9.23 Million | $-5.21 Million | -0.565x | -184.04% |
| 2011-12-31 | $-8.18 Million | $-5.49 Million | 0.672x | -80.21% |
| 2010-12-31 | $-1.90 Million | $-6.45 Million | 3.395x | +254.53% |
| 2009-12-31 | $2.64 Million | $-5.80 Million | -2.197x | -110.15% |
| 2008-12-31 | $-177.25K | $-3.84 Million | 21.637x | +1026.98% |
| 2007-12-31 | $819.88K | $-1.91 Million | -2.334x | -34.13% |
| 2006-12-31 | $1.28 Million | $-2.22 Million | -1.740x | +10.23% |
| 2005-12-31 | $1.77 Million | $-3.43 Million | -1.939x | -185.04% |
| 2004-12-31 | $4.04 Million | $-2.75 Million | -0.680x | -91.94% |
| 2003-12-31 | $3.44 Million | $-1.22 Million | -0.354x | -- |